To obtain direct evidence for the involvement of the RAS-RAF-MEK-ERK and PI3K-AKT/PKB-mTOR pathways in increasing the resistance of gliomas to the induction of programmed cell death by chemotherapeutics, we blocked the expression of RAF and PI3K kinases by specific siRNAs. The gene discussed is MAP2K7; the disease is glioma.